The current landscape of standard of care and new drug development in HER2+ metastatic breast cancer

The current landscape of standard of care and new drug development in HER2+ metastatic breast cancer

E-session 505000 / NO CME Add to My Agenda Remove from My Agenda

Expert:

Philippe Aftimos, expert of session 'The current landscape of standard of care and new drug development in HER2+ metastatic breast cancer'

Philippe Aftimos
Jules Bordet Institute
Brussels, Belgium

Enter the recorded session

Share on:

18
Nov 2019
18:15-19:00 CET

Top